RenaissanceRe (RNR) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
4 Feb, 2026Executive summary
Net income available to common shareholders was $2.65 billion for 2025, with operating income of $1.9 billion, and Q4 net income at $751.6 million.
Book value per common share increased to $247.00 at year-end 2025, with tangible book value per share plus accumulated dividends up 30.8% year-over-year.
Return on average common equity was 25.9% for 2025, with operating ROE at 18.2%.
Repurchased $1.6 billion of common shares in 2025, reducing share count by 12.8%.
Successfully integrated acquisitions, optimized operations, and upgraded underwriting systems for efficiency and AI integration.
Financial highlights
Gross premiums written for 2025 were $11.74 billion, net premiums written $9.9 billion, both flat year-over-year.
Underwriting income for 2025 was $1.62 billion, including a $1.1 billion underwriting loss from California wildfires.
Total investment result for 2025 was $3.0 billion, up 77% year-over-year, with $1.2 billion in mark-to-market gains.
Fee income for 2025 was $329 million, with management fees at $207 million and performance fees at $121 million.
Combined ratio for 2025 was 87.2%, adjusted combined ratio 85.4%, both impacted by large loss events.
Outlook and guidance
Management expects continued strong results in 2026, with robust underwriting, fee, and investment income.
Property Cat premiums expected to be down mid-single digits in 2026, with rate adequacy remaining strong.
Operating expense ratio projected to average 5%-5.5% in 2026, after Bermuda tax credits.
Management fees expected to be around $50 million and performance fees around $30 million in Q1 2026.
Ongoing uncertainties include macroeconomic, geopolitical, and regulatory changes.
Latest events from RenaissanceRe
- Key votes include director elections, executive pay, incentive plan, and auditor appointment.RNR
Proxy Filing18 Mar 2026 - 2025 saw record returns, board refreshment, and enhanced ESG focus, with all proposals recommended for approval.RNR
Proxy Filing18 Mar 2026 - Q2 2024 saw $495M net income, 29% premium growth, and strong returns from Validus.RNR
Q2 20242 Feb 2026 - Q3 net income soared to $1.17B, with strong premium growth and investment gains.RNR
Q3 202415 Jan 2026 - Record $2.2B operating income and 26% tangible book value growth despite catastrophe losses.RNR
Q4 20249 Jan 2026 - Catastrophe losses led to an operating loss, but investment gains and capital strength persisted.RNR
Q1 202520 Dec 2025 - 2024 saw record growth, strategic integration, and enhanced governance, with all proposals recommended for approval.RNR
Proxy Filing2 Dec 2025 - Key votes include director elections, executive pay, and auditor approval for 2025.RNR
Proxy Filing2 Dec 2025 - Q2 2025 net income rose 67% with a 75.1% combined ratio and strong book value growth.RNR
Q2 20255 Nov 2025